
News|Articles|December 1, 2010
Formulary Digital Edition December 2010
Focus on 2010: A year of novel pharmacologic agents in review; Azilsartan: A next-generation angiotensin II receptor blocker for the treatment of hypertension; Agents in late-stage development for the treatment of eye diseases
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Zepbound linked to lower healthcare costs in older adults with obesity
2
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
3
FDA approves brepocitinib for rare skin disease
4
Biosimilars provide modest cost savings for cancer patients, study finds
5













